Antengene Receives Approval for XPOVIO for Commercialisation in Thailand
This successful approval for XPOVIO in Thailand will introduce novel therapies to the clinical management of patients with MM in Thailand, benefiting many patients and their families in the country.
Thailand Food And Drug Administration | 24/09/2024 | By Aishwarya | 101
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy